Healthy men help compare new drug to enbrel
NCT ID NCT06392074
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 34 times
Summary
This study tested a new biosimilar drug (MB04) against two versions of Enbrel in 141 healthy men. The goal was to see how the drugs move through the body and if they cause side effects or immune reactions. Participants received a single dose and had blood samples taken over several days to measure drug levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Clinical Research Unit
Groningen, Provincie Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.